l-cafedrine
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 7, 2011 (NCT01311414)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Loading structure…
SMILES
CC(NCCn1cnc2c1c(=O)n(C)c(=O)n2C)C(O)c1ccccc1- Mol. weight
- 357.41 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2104207 ↗
Also known as
- 7-(2-(1-methyl-2-hydroxy-2-phenylethylamino)ethyl)theophylline
- cafedrine
- cafedrine
- cafedrine
- cafedrine
- cafedrine
- cafedrine
- cafedrine
- cafedrine
- (-)-cafedrine
- cafedrine hydrochloride
- l-cafedrine
- norephendrinetheophylline
- norephendrinetheophylline mono-hydrochloride, (r-(r*,s*))-isomer
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01311414 | N/A | Mar 7, 2011 | Universitaetsklinikum Schleswig-Holstein |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Universitaetsklinikum Schleswig-Holstein | Academic/Hospital | 1 | 1 | 1 | 2011 |
1 organizations
Page 1 / 1